Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Feb 28:8:57.
doi: 10.3389/fnbeh.2014.00057. eCollection 2014.

Optogenetic and chemogenetic insights into the food addiction hypothesis

Affiliations
Review

Optogenetic and chemogenetic insights into the food addiction hypothesis

Michael J Krashes et al. Front Behav Neurosci. .

Abstract

Obesity is clinically diagnosed by a simple formula based on the weight and height of a person (body mass index), but is associated with a host of other behavioral symptoms that are likely neurological in origin. In recent years, many scientists have asked whether similar behavioral and cognitive changes occur in drug addiction and obesity, lending many to discuss the potential for "food addiction". Advances in understanding the circuitry underlying both feeding behaviors and drug addiction may allow us to consider this question from the viewpoint of neural circuits, to complement behavioral perspectives. Here, we review advances in understanding of these circuits and use them to consider whether drawing comparisons to drug addiction is helpful for understanding certain forms of obesity.

Keywords: addiction; arcuate; feeding; food; obesity; optogenetics; striatum.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Number of papers published per year from 1912–2012 containing the term “drug addiction” or “food addiction” in the title or abstract. Results from a Pubmed search on 11/08/13, using tools from the Neuroscience Information Framework (NIF). RIID:nif-0000-25673

References

    1. Adamantidis A. R., Tsai H. C., Boutrel B., Zhang F., Stuber G. D., Budygin E. A., et al. (2011). Optogenetic interrogation of dopaminergic modulation of the multiple phases of reward-seeking behavior. J. Neurosci. 31, 10829–10835 10.1523/JNEUROSCI.2246-11.2011 - DOI - PMC - PubMed
    1. Adan R. A. (2013). Mechanisms underlying current and future anti-obesity drugs. Trends Neurosci. 36, 133–140 10.1016/j.tins.2012.12.001 - DOI - PubMed
    1. Albin R. L., Young A. B., Penney J. B. (1989). The functional anatomy of basal ganglia disorders. Trends Neurosci. 12, 366–375 10.1016/0166-2236(89)90074-x - DOI - PubMed
    1. Alvarez-Castro P., Pena L., Cordido F. (2013). Ghrelin in obesity, physiological and pharmacological considerations. Mini. Rev. Med. Chem. 13, 541–552 10.2174/1389557511313040007 - DOI - PubMed
    1. Anstrom K. K., Miczek K. A., Budygin E. A. (2009). Increased phasic dopamine signaling in the mesolimbic pathway during social defeat in rats. Neuroscience 161, 3–12 10.1016/j.neuroscience.2009.03.023 - DOI - PMC - PubMed

LinkOut - more resources